COMMUNIQUÉS West-GlobeNewswire

Global Blood Therapeutics Prices a $150.0 Million Common Stock Public Offering

07/12/2018 - 15:15

SOUTH SAN FRANCISCO, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT), a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative [...]

Oxford Immunotec Announces Regulatory Acceptance of T-Cell Select™ in China

07/12/2018 - 15:00

OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced regulatory acceptance of the T-Cell [...]

Site Visit Planned for December 19, 2018 to Initiate Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer

07/12/2018 - 15:00

BATON ROUGE, La., Dec. 07, 2018 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

How to Lower Healthcare Costs: Advice to Congress from AAPS President Marilyn Singleton, M.D., J.D.

07/12/2018 - 14:48

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Health-related costs have soared from about 5 percent of the average household’s annual spending in 1984 to 8 percent now, writes Marilyn Singleton , M.D., J.D., in the [...]

Re-analysis of CDC Data Suggests Need for Further Investigation on MMR Vaccine and Autism, according to Article in the Journal of American Physicians and Surgeons

07/12/2018 - 14:43

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- As early as 2001, the Centers for Disease Control and Prevention (CDC) had data showing an increased rate of autism diagnoses in black male schoolchildren in Atlanta who [...]

Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer

07/12/2018 - 14:32

SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that academic researchers from the Technical University of Munich (TUM) [...]

Biome Grow Signs Massive Provincial Supply Agreement-- CFN Media

07/12/2018 - 14:30

SEATTLE, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Gala Pharmaceutical Files State License Application for Testing Facility

07/12/2018 - 14:30

IRVINE, Calif., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. (Ticker: GLPH), a robust and burgeoning Analytical testing company, today announced notable progress toward opening its doors and serving its [...]

Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium

07/12/2018 - 14:30

EndoPredict is the Only Test to Answer Three Critical Questions: Risk of Breast Cancer Recurrence, Benefits of Chemotherapy and Who Can Forgo Extended Endocrine Therapy SALT LAKE CITY, Dec. 07, 2018 (GLOBE NEWSWIRE) -- [...]

Physician-Assisted Death and Lifeboat Ethics Pre-empt Oath of Hippocrates, States the Journal of American Physicians and Surgeons

07/12/2018 - 14:25

TUCSON, Ariz., Dec. 07, 2018 (GLOBE NEWSWIRE) -- Physician-assisted suicide (PAS) or physician-assisted death (PAD) are now receiving strong public support, writes Jeffrey Hall Dobken , M.D., M.P.H., in the winter issue [...]

iCAD Announces FDA Clearance of ProFound AI™ for Digital Breast Tomosynthesis

07/12/2018 - 14:00

High-performance, cancer detection technology built on artificial intelligence now available to healthcare facilities in the U.S. New U.S. clearance based on clinical results demonstrating unprecedented improvements in [...]

MediPets CBD Infused Dog Treats Win Prestigious Industry Award

07/12/2018 - 14:00

PotNetwork Holdings subsidiary wins 2018 Pet Industry Recognition Award in Dog Treats Functional Category MIAMI, Dec. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Diamond CBD Inc., a wholly-owned subsidiary of [...]

DIAMEDICA ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING AND NASDAQ LISTING

07/12/2018 - 13:00

MINNEAPOLIS, Dec. 07, 2018 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (“DiaMedica”) (NASDAQ:DMAC) (TSX‑V:DMA), a clinical stage biopharmaceutical company, announced today the pricing of its initial public offering [...]

T2 Biosystems Reports Granting of Inducement Awards

07/12/2018 - 13:00

LEXINGTON, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]

Heuro Canada First to Bring Revolutionary Neurological Health Technology to Canada

07/12/2018 - 11:00

Leader in traumatic brain injury management aims to change how Canadians address their neurological health SURREY, British Columbia, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Heuro Canada Inc., a leading provider of innovative [...]

Rule 2.9 Announcement

07/12/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 7 December 2018 [...]

Sensorion Announces a Publication in Hearing Research on Kinetics of Prestin Blood Levels After Noise Trauma-Induced Hearing Loss

07/12/2018 - 07:35

Circulating levels of prestin may act as surrogate biomarker for hearing loss involving OHC loss MONTPELLIER, France, Dec. 07, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN) , a biotech company specializing [...]

Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock

07/12/2018 - 03:57

MINNEAPOLIS, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

UPDATE: Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock

07/12/2018 - 03:56

CAMBRIDGE, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]